Cart summary

You have no items in your shopping cart.

PD176252

SKU: orb1706834

Description

PD176252 is a dual bombesin receptor (BB1/BB2) antagonist and a formyl peptide receptor (FPR1/FPR2) agonist. This small molecule inhibitor suppresses cancer cell growth and proliferation, making it a valuable tool for oncology research in both in vitro and in vivo models.

Research Area

Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number204067-01-6
MW584.67
Purity99.18% (May vary between batches)
FormulaC32H36N6O5
SMILESCOc1ccc(nc1)C1(CNC(=O)[C@](C)(Cc2c[nH]c3ccccc23)NC(=O)Nc2ccc(cc2)[N+]([O-])=O)CCCCC1
TargetBombesin Receptor
SolubilityDMSO:100 mg/mL (171.04 mM);10% DMSO+90% Corn Oil:5 mg/mL (8.55 mM)

Bioactivity

Target IC50
FPR1:0.31 μM (EC50)|BB1 receptor:0.66 nM (Ki, Rat)|BB1 receptor:0.17 nM (Ki, Human)|FPR:0.72±0.21 μM (EC50, human)|BB2 receptor:16 nM (Rat)|BB2 receptor:1 nM (Ki, Human)|FPR2:0.66 μM (EC50)
In Vivo
Orally administered PD176252 (1, 10 μg) potently inhibits the growth and proliferation of NCI-H1299 xenografts in nude mice.
In Vitro
PD176252 is a potent antagonist of neuromedin-B preferring (BB1) and gastrin-releasing peptide-preferring (BB2) receptors, with Kis of 0.17 nM and 1 nM for human BB1 and BB2, and 0.66 nM and 16 nM for rat BB1 and BB2 receptors, respectively. In CHO cells expressing human BB1 or BB2 receptors, PD176252 inhibits acidification responses to neuromedin-B or neuromedin-C with appKBs of 4.0 nM and 13 nM, respectively. It also blocks bombesin-evoked increases in intracellular calcium levels, with appKBs of 2.3 nM and 36 nM, respectively. Additionally, PD176252 is an agonist of N-Formyl peptide receptor1/2 (FPR1/FPR2), with EC50s of 0.31 and 0.66 μM in HL-60 cells, activating Ca2+ mobilization in HL-60 cells transfected with human FPRs (EC50, 0.72 ± 0.21 μM). PD176252 shows little specific 125I-gastrin releasing peptide binding to NCI-H345 cells at 1 nM but suppresses almost all specific binding at 1000 nM, with an IC50 of 30 nM. Furthermore, PD176252 (10, 30 μM) significantly inhibits the growth of NCI-H345 or H1299 cells, with IC50s of 7 and 5 μM.

Storage & Handling

Storagestore under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

BB1, BB2, BombesinReceptor, Bombesin Receptor, PD176252, PD-176252, PD 176252, Human BB1 receptor, Human BB2 receptor, FPR2, FPR1, Rat BB1 receptor, Rat BB2 receptor
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

PD176252 (orb1706834)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 mg
$ 70.00
5 mg
$ 110.00
1 ml x 10 mM (in DMSO)
$ 120.00
10 mg
$ 170.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry